Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
Senior Chinese official calls for determined, forceful crack down on commercial bribery
4/30/2006
Senior Chinese official Wu Guanzheng yesterday called for determined and forceful measures to crack down on commercial bribery.
Wu, a member of the Standing Committee of the Political Bureau of the Central Committee of the Communist Party of China (CPC) made the remarks at an executive meeting of the leading group of the national anti-commercial bribery.
The crack down on commercial bribery should focus on the issues of people's concern that seriously harm the public interests and disturb the market order, especially in areas including construction, lease of land-use property, property trade, pharmaceutical purchase, government procurement and resource developing and trading, he said.
Wu, also secretary of the CPC Central Commission for Discipline Inspection, said that civil servants who abuse their power in involvement or interference with the business of entrepreneurial or institutional units to seek bribery or illegal profits should be severely punished.
He called for the speedup of the establishment of a credit system to better impose management and supervision over related transactions.
The crack down on commercial bribery should be based on China's realities, Wu said, adding that China should also enhance exchanges with other countries and learn from their experiences in fighting against commercial bribery.
Relate News
more
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit